全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Infección asintomática por el virus influenza H1N1 (2009) en personal sanitario: Estudio Marbegrip. Resultados preliminares

DOI: 10.1590/S1135-57272011000100008

Keywords: human influenza, prevalence, health personnel, hemagglutination inhibition.

Full-Text   Cite this paper   Add to My Lib

Abstract:

background: the proportion of asymptomatic individuals infected by influenza ah1n1v varies depending on the studies. health personnel were exposed to the ah1n1v virus due to their professional activity, thus an high seroprevalence to the virus could be expected in the absence of symptomatology. the objective of this study was to determine the prevalence of asymptomatic individuals serologically positive for influenza ah1n1v virus. methods: a cohort based prospective study on hospital staff was proposed according to an hypothetic decreasing gradient of exposure to the virus, from emergency personnel to medical and surgical areas, and auxiliary staff other than emergency personnel. serum sample from each participant was taken in september-october, 2009, november-december, 2009, and in april-may, 2010; and a health questionnaire was simultaneously filled out. specific antibodies against influenza ah1n1v were detected by hemagglutination inhibition test. eighteen hospitals (1,371 individuals) participated in the study. results: health questionnaire and serological results from four hospitals are available. a variable proportion of non vaccinated individuals showed positive serology (5.6-83%). only 19.4% of subjects received vaccine, with a variable rate of positive serology (18.8-64.7%). positive serology was significantly lower in non medical participants. in addition, vaccine coverage was higher in medical personnel than in the rest of professional categories conclusions: there was a variable percentage of influenza ah1n1v seropositive individuals who had not suffered clinical symptomatology. this serological study detects differences on vaccine efficacy.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413